Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series

BACKGROUND: Severe psoriasis vulgaris can be extremely difficult to treat in some patients, even with the newer biological therapies available today. CASE PRESENTATIONS: We present two patients with severe chronic plaque psoriasis who received numerous systemic anti-psoriatic therapies with varied r...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowes, Michelle A, Turton, James A, Krueger, James G, Barnetson, Ross StC
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1208875/
https://www.ncbi.nlm.nih.gov/pubmed/16109173
http://dx.doi.org/10.1186/1471-5945-5-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1208875/
https://www.ncbi.nlm.nih.gov/pubmed/16109173
http://dx.doi.org/10.1186/1471-5945-5-9

Ejemplares similares